Subcutaneous injection delivers GHK-Cu directly into circulation where it can cross the blood-brain barrier and exert central effects
A concentration of only 1 mM GSH was determined to be sufficient for high recovery, but lower concentrations of GSH were investigated across a 1001,000 M GSH gradient to evaluate a potential separation of empty and full capsids
Key Features Research-grade GHK-CU supplied in a nasal solution format 1mg/mL concentration ensuring precise dosing for experimental protocols 30mL volume suitable for multiple laboratory assays Batch-controlled quality with documentation for reproducibility Storage recommendations to preserve compound stability Strictly for non-clinical, research use only Related Research Areas GHK-CU is often studied alongside other copper-binding peptides and research peptides within the broader category of biochemical modulators
Balana AT, Mahul-Mellier AL, Nguyen BA, Horvath M, Javed A, Hard ER, et al
Outside of work she enjoys spending time outdoors enjoying a good book or exercising with her local gym community
Cooperativity between the orthosteric and allosteric ligand binding sites of RORgammat